Catalys Pacific, LLC

Holdings History for Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

Symbol: MLYS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	92%	-12%	$286,830,281	7,903,838	-1,000,000	-11%	$36.29	Q4 2025
30 Sep 2025	96%	0%	$337,633,537	8,903,838	0		$37.92	Q3 2025
30 Jun 2025	91%	0%	$120,468,928	8,903,838	0		$13.53	Q2 2025
31 Mar 2025	95%	+2.8%	$141,392,947	8,903,838	+259,259	+3%	$15.88	Q1 2025
31 Dec 2024	92%	0%	$106,414,767	8,644,579	0		$12.31	Q4 2024
30 Sep 2024	83%	-5.3%	$104,685,852	8,644,579	-550,000	-6%	$12.11	Q3 2024
30 Jun 2024	81%	0%	$107,576,574	9,194,579	0		$11.70	Q2 2024
31 Mar 2024	80%	0%	$118,702,015	9,194,579	0		$12.91	Q1 2024
31 Dec 2023	74%	0%	$79,073,379	9,194,579	0		$8.60	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.